It Takes An Abuser To Find Abuse Potential, Janssen Tells FDA
Executive Summary
Evaluation of an abuse-deterrent opioid could include a study of abusers’ ability to manipulate the drugs with non-laboratory-grade tools, the company says in comments on FDA guidance.